Join to View Full Profile
3400 Civic Center Blvd4th Floor, West Pavillion, PcamPhiladelphia, PA 19104
Phone+1 215-662-2300
Dr. Garin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013- University of Pennsylvania Health SystemResidency, Internal Medicine, 2008 - 2011
Washington University in St. Louis School of MedicineClass of 2008
Certifications & Licensure
PA State Medical License 2013 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 4 citationsEfficacy of Reslizumab Treatment in Exacerbation-Prone Patients with Severe Eosinophilic Asthma.Michael E. Wechsler, Lisa Hickey, Margaret Garin, Anoop Chauhan
The Journal of Allergy and Clinical Immunology. in Practice. 2020-11-01 - 42 citationsEffect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corti...Jonathan A. Bernstein, J. Christian Virchow, Kevin R. Murphy, Jorge Maspero, Joshua J. Jacobs
The Lancet. Respiratory Medicine. 2020-05-01 - 5 citationsIn patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV 1 reversibilityJ. Christian Virchow, Lisa Hickey, Evelyn Du, Margaret Garin
Allergy, Asthma, and Clinical Immunology. 2020-04-19
Journal Articles
- Original Article Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal PolypsRohit K Katial, Margaret Garin, Steven F Weinstein, ScienceDirect
Press Mentions
Eosinophilic Asthma Patients with Chronic Rhinosinusitis with Nasal Polyps Appear Highly ResponsiveSeptember 4th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
